Drug Development
Pharmacophore model predicts anti-HIV CCR5 antagonist activity
Published in AIDS Weekly, November 17th, 2003
According to published research from the United States, "Predictive pharmacophore models were developed for a large series of piperidine- and piperazine-based CCR5 antagonists as anti-HIV-1 agents reported by Schering-Plough Research Institute in recent years."
"The pharmacophore models were generated using a training set consisting of 25 carefully selected antagonists based on well documented criteria," explained A.K. Debnath and coauthors working at the New York Blood Center.
"The activity spread, expressed in K-i, of training...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2003-11-17)
More Articles from AIDS Weekly
- Gene Therapy
HIV-based vectors do not disrupt cellular transcription - HIV/AIDS Nephropathy
HIV Nef plays key role in virus-induced podocyte dedifferentiation - Fancomi Anemia
Novel lentiviral vector efficiently transduces FA stem cells - Genomics and Genetics
Genetic recombination between R5 and X4 HIV strains occurs in vivo - HIV/AIDS Dementia
Chemokine cleavage by metalloproteinase produces neurotoxic proteins in HIV patients - HIV/AIDS Therapy
Antiretroviral therapy should begin when T cells drop below 350 cells/microL - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
